Literature DB >> 12448866

Hepatitis A, B, and C in Canada. Results from the National Sentinel Health Unit Surveillance System, 1993-1995.

Susie elSaadany1, Paul Gully, Antonio Giulivi.   

Abstract

OBJECTIVES: To estimate the incidence of and to describe the risk factors that were associated with the acquisition of hepatitis A, B, and C in well-defined Canadian populations from the Sentinel Health Unit Surveillance System (SHUSS).
METHODS: We used the 1993 to 1995 data on hepatitis A, B, and C infection in Canada, collected by SHUSS, a national surveillance system established by the Laboratory Centre for Disease Control in Health Canada in 1993, through consultation and collaboration with provincial partners. We calculated the rates of, and described and discussed the risk factors that were associated with, hepatitis A, B, and C infection, based on the SHUSS surveillance data.
RESULTS: From 1993 to 1995, SHUSS reported 92 cases of hepatitis A, 89 hepatitis B, and 720 hepatitis C, yielding a rate of 3.9, 3.8, and 30.3 per 100,000, respectively. The reported rates varied substantially among participating health units, ranging from 0.8 to 8.1 per 100,000 for hepatitis A, 0.0 to 9.0 for hepatitis B, and 5.4 to 73.3 for hepatitis C. The most frequently reported risk factor for hepatitis A was a history of street drug use, followed by recent international travel and household contact with a hepatitis A case, household crowding, and a history of raw or undercooked shellfish consumption. The most frequently reported risk factors for the acquisition of hepatitis B included history of street drug use and occupational exposure. The most frequently reported risk factor for the acquisition of hepatitis C was a history of street drug use, followed by health care exposure and occupational exposure. Only 5% of persons with hepatitis B infection had a history of hepatitis B immunization.
INTERPRETATION: Despite the limitations of possible bias due to selective participation of SHUSS and the lack of information on risk factors among controls, the high exposure to known risk factors and the low rate of vaccination among hepatitis patients can provide useful information for the development of public health policies to control hepatitis A, B, and C infection in Canada.

Entities:  

Mesh:

Year:  2002        PMID: 12448866      PMCID: PMC6979889     

Source DB:  PubMed          Journal:  Can J Public Health        ISSN: 0008-4263


  8 in total

1.  Canadian Communicable Disease Surveillance System. Disease-specific case definitions and surveillance methods.

Authors: 
Journal:  Can Dis Wkly Rep       Date:  1991

2.  Hepatitis B.

Authors:  M L Tepper; P R Gully
Journal:  CMAJ       Date:  1997-04-01       Impact factor: 8.262

Review 3.  Hepatitis C.

Authors:  P R Gully; M L Tepper
Journal:  CMAJ       Date:  1997-05-15       Impact factor: 8.262

4.  The World Health report 1996--fighting disease, fostering development.

Authors: 
Journal:  World Health Forum       Date:  1997

Review 5.  Transmission of hepatitis C virus: rates, routes, and cofactors.

Authors:  M MacDonald; N Crofts; J Kaldor
Journal:  Epidemiol Rev       Date:  1996       Impact factor: 6.222

6.  45-year follow-up of hepatitis C virus infection in healthy young adults.

Authors:  L B Seeff; R N Miller; C S Rabkin; Z Buskell-Bales; K D Straley-Eason; B L Smoak; L D Johnson; S R Lee; E L Kaplan
Journal:  Ann Intern Med       Date:  2000-01-18       Impact factor: 25.391

7.  National Advisory Committee on Immunization (NACI). Statement on the prevention of hepatitis A infections.

Authors: 
Journal:  Can Commun Dis Rep       Date:  1994-08-30

Review 8.  Epidemiological patterns of hepatitis A in different parts of the world.

Authors:  I D Gust
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

  8 in total
  4 in total

1.  Epidemiological study of hepatitis B virus infection in Manitoba, Canada, 1992-2003.

Authors:  Z Hong; G Smart; G Zaniewski; H Wu; J Wu; N Goedhuis; A Giulivi; K Kaita; M Dawood
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-07       Impact factor: 3.267

2.  Cohort effects in dynamic models and their impact on vaccination programmes: an example from hepatitis A.

Authors:  Arni S R Srinivasa Rao; Maggie H Chen; Ba' Z Pham; Andrea C Tricco; Vladimir Gilca; Bernard Duval; Murray D Krahn; Chris T Bauch
Journal:  BMC Infect Dis       Date:  2006-12-05       Impact factor: 3.090

Review 3.  Seroprevalence of hepatitis A infection in a low endemicity country: a systematic review.

Authors:  Ba' Pham; Bernard Duval; Gaston De Serres; Vladimir Gilca; Andrea C Tricco; Jan Ochnio; David W Scheifele
Journal:  BMC Infect Dis       Date:  2005-07-07       Impact factor: 3.090

4.  The United States and Canada as a coupled epidemiological system: an example from hepatitis A.

Authors:  Raluca Amariei; Allan R Willms; Chris T Bauch
Journal:  BMC Infect Dis       Date:  2008-02-28       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.